[Treatment for chronic hepatitis C with thrombocytopenia]

Norihiro Furusyo, Eiichi Ogawa, Masayuki Murata, Jun Hayashi

Research output: Contribution to journalReview articlepeer-review


Thrombocytopenia in patients with chronic hepatitis C represents an obstacle for the initiation of antiviral treatment. Antiviral treatment with pegylated interferon α and ribavirin has contributed to a significant increase in the rate of sustained virological response. However, patients with thrombocytopenia is ineligible for antiviral treatment or, if able to start treatment, may require a dose reduction or even discontinuation due to the haematological adverse effects. We here review the efficacy and safety of antiviral treatment after splenectomy and partial splenic embolization, and the potential effect of platelet count increase by interferon β.

Original languageEnglish
Pages (from-to)299-303
Number of pages5
JournalNihon rinsho. Japanese journal of clinical medicine
Issue number2
Publication statusPublished - Feb 1 2015

All Science Journal Classification (ASJC) codes

  • Medicine(all)


Dive into the research topics of '[Treatment for chronic hepatitis C with thrombocytopenia]'. Together they form a unique fingerprint.

Cite this